🇺🇸 FDA
Patent

US 7678813

Azadecalin Glucocorticoid receptor modulators

granted A61PA61P1/00A61P11/06

Quick answer

US patent 7678813 (Azadecalin Glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P1/00, A61P11/06, A61P17/02, A61P19/02